Quantity size:
0.2ml
Concentration:
1mg/ml 干扰素诱导跨膜蛋白2抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Interferons (IFNs) are potential antitumor agents, as they exhibit antiproliferative and differentiating properties, in addition to functioning in the defense against microbial infections. IFN exposure induces the regulation of expression levels of cellular proteins that mediate the pleiotropic effects of interferons. These effects may 干扰素诱导跨膜蛋白2抗体 be mediated by soluble factors or by cell-cell interactions involving specific membrane proteins. The IFITM family of proteins are transmembrane proteins so named because their expression is IFN-inducible. IFITM proteins have been found upregulated in human colorectal carcinomas. Both mouse IFITM1 (also known as CD225) and IFITM3 demonstrate expression on the cell surfaces of primordial germ cells in a developmentally-regulated manner. They presumably modulate cell adhesion and influence cell differentiation.干扰素诱导跨膜蛋白2抗体 IFITM1 activity is required for primordial germ cell transit, and IFITM1 acts as a repulsive molecule by repelling non-IFITM1-expressing primordial germ cells from the mesoderm into the endoderm.
干扰素诱导跨膜蛋白2抗体 Also known as:
1 8D; Dispanin subfamily A member 2c; DSPA2c; IFITM 2; Interferon induced transmembrane protein 2 (1 8D); IFM2_HUMAN; Interferon induced transmembrane protein 2; Interferon inducible protein 1 8D.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, .
●
Immunogen: KLH conjugated synthetic peptide derived from human IFITM2.
●
Predicted Molecular Weight: 15kDa.
干扰素诱导跨膜蛋白2抗体 Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl861Mu01补体成分3(C3)多克隆抗体Polyclonal Antibody to Complement Component 3 (C3)
kl861Po01补体成分3(C3)多克隆抗体Polyclonal Antibody to Complement Component 3 (C3)
kl861Ra01补体成分3(C3)多克隆抗体Polyclonal Antibody to Complement Component 3 (C3)
kl862Hu01补体成分2(C2)多克隆抗体Polyclonal Antibody to Complement Component 2 (C2)
kl866Bo01甲状旁腺激素(PTH)多克隆抗体Polyclonal Antibody to klathyroid Hormone (PTH)
kl866Ca01甲状旁腺激素(PTH)多克隆抗体Polyclonal Antibody to klathyroid Hormone (PTH)
kl866Ga01甲状旁腺激素(PTH)多克隆抗体Polyclonal Antibody to klathyroid Hormone (PTH)
kl866Hu01甲状旁腺激素(PTH)多克隆抗体Polyclonal Antibody to klathyroid Hormone (PTH)
kl866Mu01甲状旁腺激素(PTH)多克隆抗体Polyclonal Antibody to klathyroid Hormone (PTH)
kl866Po01甲状旁腺激素(PTH)多克隆抗体Polyclonal Antibody to klathyroid Hormone (PTH)
kl866Ra01甲状旁腺激素(PTH)多克隆抗体Polyclonal Antibody to klathyroid Hormone (PTH)
kl867Hu01脂蛋白关联磷脂酶A2(LpPLA2)多克隆抗体Polyclonal Antibody to Phospholikle A2, Lipoprotein Associated (LpPLA2)
kl867Mu01脂蛋白关联磷脂酶A2(LpPLA2)多克隆抗体Polyclonal Antibody to Phospholikle A2, Lipoprotein Associated (LpPLA2)
kl867Ra01脂蛋白关联磷脂酶A2(LpPLA2)多克隆抗体Polyclonal Antibody to Phospholikle A2, Lipoprotein Associated (LpPLA2)
kl868Hu01内皮型一氧化氮合酶(NOS3)多克隆抗体Polyclonal Antibody to Nitric Oxide Synthase 3, Endothelial (NOS3)
kl868Mu01内皮型一氧化氮合酶(NOS3)多克隆抗体Polyclonal Antibody to Nitric Oxide Synthase 3, Endothelial (NOS3)
kl868Po01内皮型一氧化氮合酶(NOS3)多克隆抗体Polyclonal Antibody to Nitric Oxide Synthase 3, Endothelial (NOS3)
kl868Ra01内皮型一氧化氮合酶(NOS3)多克隆抗体Polyclonal Antibody to Nitric Oxide Synthase 3, Endothelial (NOS3)
kl868Rb51内皮型一氧化氮合酶(NOS3)多克隆抗体Polyclonal Antibody to Nitric Oxide Synthase 3, Endothelial (NOS3)
kl871Ga01热休克蛋白β2(HSPβ2)多克隆抗体Polyclonal Antibody to Heat Shock Protein Beta 2 (HSPb2)
kl871Hu01热休克蛋白β2(HSPβ2)多克隆抗体Polyclonal Antibody to Heat Shock Protein Beta 2 (HSPb2)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话